Sequoia invests in Chinese AI drug startup
AI and pharmaceuticals are two of the hottest sectors in China right now. Sequoia's investment in DIP covers both of them.
October 09, 2018
In October, social media platform KilaKila completed Rmb120 million ($17.2 million) Series A fundraising from Nasdaq-listed Weibo, Sequoia Capital, and venture funds that include CITIC Capital, Axpfund and Qingyu.
Registered users get 2 free articles in 30 days.
Subscribers have full unlimited access to FinanceAsia.
Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.
Questions?
See here for more information on licences and prices, or contact [email protected].